TABLE 6.

RR for MAARI and Asthma After Multiple Annual Doses of LAIV-T in Children Who Were 18 Months to 18 Years of Age

		RR 0–14 D/Prevaccination Period (95% CI)
Category	No. of Annual Doses	Year 1 (1998–1999)	Year 2 (1999–2000)	Year 3 (2000–2001)	Year 4 (2001–2002)
MAARI	1	0.85 (0.68–1.07)	0.97 (0.76–1.23)	0.77 (0.57–1.03)	0.94 (0.62–1.42)
	2		0.86 (0.65–1.14)	0.75 (0.49–1.15)	0.86 (0.43–1.69)
	3			0.61 (0.39–0.96)	0.27 (0.10–0.71)
	4				0.94 (0.51–1.74)
Asthma	1	0.49 (0.19–1.30)	1.84 (0.83–4.08)	0.65 (0.22–1.85)	1.42 (0.47–4.29)
	2		0.80 (0.32–2.02)	0.64 (0.17–2.34)	0.42 (0.05–3.58)
	3			0.0	1.80 (0.11–28.80)
	4				0.80 (0.14–4.70)

Boldface indicates a significant decrease in health care utilization.